Muscular dystrophy Clinical Trials EU — 4 Studies

Filter these 4 trials by phase, country, sponsor and more.

ATA-200 gene therapy trial in patients with LGMDR5 Pending

2023-506440-16-00 7 "limb-girdle muscular dystrophy type R5 (previously named LGM"
Effects of BBP-418 (ribitol) in Patients with LGMD2I Recruitment ended

2023-503379-33-01 5 2024-02-12 "Limb Girdle Muscular Dystrophy 2I/R9"
ATA-100 gene therapy trial in patients with limb-girdle muscular dystrophy Recruitment ended

2023-506677-36-00 7 2022-07-18 "FKRP-related limb-girdle muscular dystrophy (LGMD R9)"
Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Effect of EDG-5506 on Biomarkers in Adults with Neuromuscular Disease Ended

2022-500215-39-00 4 2022-12-06 "McArdle Disease"

Showing 1–4 of 4 trials